These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6421060)

  • 1. Effects of cryoglobulin on fibrin clot formation and fibrinolysis.
    Kataoka K; Yamada S; Toki N
    Acta Haematol; 1984; 71(2):90-6. PubMed ID: 6421060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
    Gram J
    Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A delaying influence of cryoglobulins in the assessment of euglobulin fibrinolytic activity.
    Gram J; Jespersen J; Astrup T
    Thromb Res; 1986 Mar; 41(6):781-9. PubMed ID: 2422781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
    von dem Borne PA; Cox LM; Bouma BN
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolysis and coagulation. Effect of calcium and of coagulation on the lysis of fibrin clots.
    Helle I
    Scand J Haematol Suppl; 1968; 4():1-46. PubMed ID: 4181525
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro effects of aspirin in fibrinolysis.
    Iatridis PG; Iatridis SG; Markidou SG; Ragatz BH
    Haemostasis; 1974; 3(1):55-64. PubMed ID: 4279872
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased plasma clot permeability and susceptibility to lysis are associated with heavy menstrual bleeding of unknown cause: a case-control study.
    Szczepaniak P; Zabczyk M; Undas A
    PLoS One; 2015; 10(4):e0125069. PubMed ID: 25909989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.
    Konieczynska M; Fil K; Bazanek M; Undas A
    Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
    Jankun J; Aleem AM; Selman SH; Skrzypczak-Jankun E; Lysiak-Szydlowska W; Grafos N; Fryer HJ; Greenfield RS
    Int J Mol Med; 2007 Nov; 20(5):683-7. PubMed ID: 17912461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Denser plasma clot formation and impaired fibrinolysis in paroxysmal and persistent atrial fibrillation while on sinus rhythm: association with thrombin generation, endothelial injury and platelet activation.
    Drabik L; Wołkow P; Undas A
    Thromb Res; 2015 Aug; 136(2):408-14. PubMed ID: 26048399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrin clot lysis assay: Establishment of a reference interval.
    Neergaard-Petersen S; Mogensen VB; Veirup MS; Grove EL; Kristensen SD; Hvas AM
    Thromb Res; 2018 Jul; 167():9-11. PubMed ID: 29753280
    [No Abstract]   [Full Text] [Related]  

  • 12. A new device for measurement of fibrin clot lysis: application to the euglobulin clot lysis time.
    Boudjeltia KZ; Cauchie P; Remacle C; Guillaume M; Brohée D; Hubert JL; Vanhaeverbeek M
    BMC Biotechnol; 2002 May; 2():8. PubMed ID: 11985782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis.
    Gould TJ; Vu TT; Stafford AR; Dwivedi DJ; Kim PY; Fox-Robichaud AE; Weitz JI; Liaw PC
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2544-53. PubMed ID: 26494232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of low molecular weight heparins on fibrin polymerization and clot sensitivity to t-PA-induced lysis.
    Parise P; Morini M; Agnelli G; Ascani A; Nenci GG
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):721-7. PubMed ID: 8292721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [THROMBIN-MEDIATED EFFECTS OF BLOOD MICROPARTICLES ON FORMATION, STRUCTURE, AND STABILITY OF FIBRIN CLOTS].
    Nabiullina RM; Mustafin IG; Ataullakhanov FI; Litvinov RI; Zubairova LD
    Ross Fiziol Zh Im I M Sechenova; 2015 Jul; 101(7):812-21. PubMed ID: 26591054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theory of blood coagulation in disseminated intravascular coagulation (D. I. C.).
    Murano G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 97(1):5-19. PubMed ID: 4114585
    [No Abstract]   [Full Text] [Related]  

  • 17. [Relationship among coagulation, fibrinolysis, kinin formation and factor XII].
    Saito H
    Rinsho Ketsueki; 1978 Jun; 19(6):785-91. PubMed ID: 713043
    [No Abstract]   [Full Text] [Related]  

  • 18. The thrombin activation pathway modulates the assembly, structure and lysis of human plasma clots in vitro.
    Torbet J
    Thromb Haemost; 1995 May; 73(5):785-92. PubMed ID: 7482404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered fibrin clot properties in patients with chronic heart failure and sinus rhythm: a novel prothrombotic mechanism.
    Palka I; Nessler J; Nessler B; Piwowarska W; Tracz W; Undas A
    Heart; 2010 Jul; 96(14):1114-8. PubMed ID: 20610458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of kringles K1-3, K4 and K5 on lysis of fibrin clots caused by the activation of Glu- and Lys-plasminogen by a tissue activator].
    Taran LD; Makogonenko EM
    Ukr Biokhim Zh (1978); 1989; 61(4):31-6. PubMed ID: 2511651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.